A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs.
Spooner RA, Friedlos F, Maycroft K, Stribbling SM, Roussel J, Brueggen J, Stolz B, O'Reilly T, Wood J, Matter A, Marais R, Springer CJ.
Spooner RA, et al. Among authors: stribbling sm.
Br J Cancer. 2003 May 19;88(10):1622-30. doi: 10.1038/sj.bjc.6600911.
Br J Cancer. 2003.
PMID: 12771932
Free PMC article.